Abstract
Adrenaline is a powerful stimulus of glucagon secretion. It acts by activation of β-adrenergic receptors, but the downstream mechanisms have only been partially elucidated. Here, we have examined the effects of adrenaline in mouse and human α-cells by a combination of electrophysiology, imaging of Ca2+ and PKA activity, and hormone release measurements. We found that stimulation of glucagon secretion correlated with a PKA- and EPAC2-dependent (inhibited by PKI and ESI-05, respectively) elevation of [Ca2+]i in α-cells, which occurred without stimulation of electrical activity and persisted in the absence of extracellular Ca2+ but was sensitive to ryanodine, bafilomycin, and thapsigargin. Adrenaline also increased [Ca2+]i in α-cells in human islets. Genetic or pharmacological inhibition of the Tpc2 channel (that mediates Ca2+ release from acidic intracellular stores) abolished the stimulatory effect of adrenaline on glucagon secretion and reduced the elevation of [Ca2+]i Furthermore, in Tpc2-deficient islets, ryanodine exerted no additive inhibitory effect. These data suggest that β-adrenergic stimulation of glucagon secretion is controlled by a hierarchy of [Ca2+]i signaling in the α-cell that is initiated by cAMP-induced Tpc2-dependent Ca2+ release from the acidic stores and further amplified by Ca2+-induced Ca2+ release from the sarco/endoplasmic reticulum.
© 2018 by the American Diabetes Association.
Publication types
-
Comparative Study
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adrenergic Neurons / cytology
-
Adrenergic Neurons / drug effects
-
Adrenergic Neurons / metabolism
-
Animals
-
Animals, Outbred Strains
-
Calcium Channels / chemistry
-
Calcium Channels / genetics
-
Calcium Channels / metabolism*
-
Calcium Signaling* / drug effects
-
Cyclic AMP-Dependent Protein Kinases / antagonists & inhibitors
-
Cyclic AMP-Dependent Protein Kinases / metabolism
-
Endoplasmic Reticulum / drug effects
-
Endoplasmic Reticulum / enzymology
-
Endoplasmic Reticulum / metabolism
-
Enzyme Inhibitors / pharmacology
-
Epinephrine / metabolism*
-
Glucagon / metabolism*
-
Glucagon-Secreting Cells / cytology
-
Glucagon-Secreting Cells / drug effects
-
Glucagon-Secreting Cells / metabolism*
-
Guanine Nucleotide Exchange Factors / antagonists & inhibitors
-
Guanine Nucleotide Exchange Factors / metabolism
-
Humans
-
Membrane Transport Modulators / pharmacology
-
Mice
-
Mice, Inbred C57BL
-
Mice, Knockout
-
Pancreas / drug effects
-
Pancreas / innervation
-
Pancreas / metabolism
-
Patch-Clamp Techniques
-
Sarcoplasmic Reticulum / drug effects
-
Sarcoplasmic Reticulum / enzymology
-
Sarcoplasmic Reticulum / metabolism
-
Tissue Culture Techniques
-
Up-Regulation* / drug effects
Substances
-
Calcium Channels
-
Enzyme Inhibitors
-
Guanine Nucleotide Exchange Factors
-
Membrane Transport Modulators
-
TPCN2 protein, human
-
TPCN2 protein, mouse
-
Glucagon
-
Cyclic AMP-Dependent Protein Kinases
-
Epinephrine